Our research further clarified the anti-tumor mechanism of lycorine, suggesting that lycorine-mediated ROCK1 activation and mitochondria-dependent apoptosis may be a novel therapeutic strategy for hepatoblastoma treatment. The gene discussed is ROCK1; the disease is hepatoblastoma.